Intracellular Localization Studies of the Luminescent Analogue of an Anticancer Ruthenium Iminophosphorane with High Efficacy in a Triple-Negative Breast Cancer Mouse Model

The potential of ruthenium(II) compounds as an alternative to platinum-based clinical anticancer agents has been unveiled after extensive research for over 2 decades. As opposed to cisplatin, ruthenium(II) compounds have distinct mechanisms of action that do not rely solely on interactions with DNA. In a previous report from our group, we described the synthesis, characterization, and biological evaluation of a cationic, water-soluble, organometallic ruthenium(II) iminophosphorane (IM) complex of p-cymene, ([(η6-p-cymene)Ru{(Ph3P═N-CO-2N-C5H4)-κ-N,O}Cl]Cl (1 or Ru-IM), that was found to be highly cytotoxic against a panel of cell lines resistant to cisplatin, including triple-negative breast cancer (TNBC) MDA-MB-231, through canonical or caspase-dependent apoptosis. Studies on a MDA-MB-231 xenograft mice model (after 28 days of treatment) afforded an excellent tumor reduction of 56%, with almost negligible systemic toxicity, and a favored ruthenium tumor accumulation compared to other organs. 1 is known to only interact weakly with DNA, but its intracellular distribution and ultimate targets remain unknown. To gain insight on potential mechanisms for this highly efficacious ruthenium compound, we have developed two luminescent analogues containing the BOPIPY fluorophore (or a modification) in the IM scaffold with the general structure of [(η6-p-cymene)Ru{(BODIPY-Ph2P═N-CO-2-NC5H4)-κ-N,O}Cl]Cl {BODIPY-Ph2P = 8-[(4-diphenylphosphino)phenyl]-4,4-dimethyl-1,3,5,7-tetramethyl-2,6-diethyl-4-bora-3a,4a-diaza-s-indacene (3a) and 4,4-difluoro-8-[4-[[2-[4-(diphenylphosphino)benzamido]ethyl]carbamoyl]phenyl]-1,3,5,7-tetramethyl,2,6-diethyl-4-bora-3a,4a-diaza-s-indacene (3b)}. We report on the synthesis, characterization, lipophilicity, stability, luminescence properties, and cell viability studies in the TNBC cell line MDA-MB-231, nonmalignant breast cells (MCF10a), and lung fibroblasts (IMR-90) of the new compounds. The ruthenium derivative 3b was studied by fluorescence confocal microscopy. These studies point to a preferential accumulation of the compound in the endoplasmic reticulum, mitochondria, and lysosomes. Inductively coupled plasma optical emission spectrometry (ICP-OES) analysis also confirms a greater ruthenium accumulation in the cytoplasmic fraction, including endoplasmic reticulum and lysosomes, and a smaller percentage of accumulation in mitochondria and the nucleus. ICP-OES analysis of the parent compound 1 indicates that it accumulates preferentially in the mitochondria and cytoplasm. Subsequent experiments in 1-treated MDA-MB-231 cells demonstrate significant reactive oxygen species generation.

Redox switchable catalysis utilizing a fluorescent dye

This report describes the implementation of a 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene (BODIPY) dye into the ligand framework of a Rh-based catalyst. The redox-active nature of the BODIPY dye is utilized to generate a catalyst that is capable of exhibiting redox-switchable catalytic behavior for the hydroboration of alkenes through a BODIPY-based reduction.

Fluorescent functionalised naphthalimides and their Au(i)–NHC complexes for potential use in cellular bioimaging

A series of fluorescent gold(i)–NHC complexes have been developed and investigated as cell imaging agents.

Stability of a Series of BODIPYs in Acidic Conditions: An Experimental and Computational Study into the Role of the Substituents at Boron

Boron-dipyrromethene (BODIPY) dyes have been extensively investigated in recent years for a variety of bioanalytical and bioimaging applications. The success of these applications relies on the stability of BODIPYs, particularly under acidic conditions. In this work, the stability of a series of 4,4'-disubstituted BODIPYs (-F, -CN, -Ph, -Me, -OMe) toward addition of excess trifluoroacetic acid (TFA) was studied systematically and comprehensively through ¹¹B and ¹H NMR, UV-vis, fluorescence, thin layer chromatography, mass spectrometry, and infrared. The results indicate that 4,4'-dicyano-BODIPY 2 is the most stable among this series and remains unchanged even 3 days after addition of excess TFA. On the other hand, 4,4'-dimethyl-BODIPY 3 and 4,4'-dimethoxy-BODIPY 5 are the least stable, toward addition of TFA, and the 4,4'-diphenyl and 4,4'-difluoro-BODIPYs 1 and 4 were found to have intermediate stability. The experimental analysis and comparison with theoretical calculations indicate that the 4,4'-dicyano-BODIPY 2 has the greater aromaticity of the series, as evaluated by the BLA parameter, decreased charge on boron, and upon TFA addition it forms an unusually stable BODIPY 2···TFA complex. On the other hand, all other BODIPYs decompose within hours after TFA addition. Computational modeling demonstrates that 4,4'-dicyano substitution increases aromaticity and stabilizes the B-N bond, resulting in the most stable compound from the series studied.

Pure-color and dual-color emission from BODIPY homopolymers containing the cardo boron structure

Pure-color and dual-color emission were accomplished with homopolymers composed of modified boron dipyrromethene involving cardo boron.

Anion sensing with a Lewis acidic BODIPY-antimony(v) derivative

Modification of a BODIPY dye with a Lewis acidic antimony group affords a fluorescent fluoride and cyanide sensor.

Mono- and dimeric complexes of an asymmetric heterotopic P,CNHC,pyr ligand

An asymmetric heterotopic ligand (S-N(Me)CP) containing a central bicyclic, expanded-ring NHC with one pyridyl and one phosphine exo-substituent has been synthesised and its coordination chemistry with selected late transition metals investigated. The amidinium precursor [S-N(Me)CHP]PF6 shows variable coordination modes with Ag(i), Cu(i) and Au(i) depending on the L : M ratio. The reaction of two mols of [S-N(Me)CHP]PF6 with [Cu(MeCN)4]BF4, AgBF4 or Au(THT)Cl gives the bis-ligand complexes [Cu(κ-P-N(Me)CHP)2(CH3CN)2]BF4·(PF6)2, 1, and [M(κ-P-N(Me)CHP)2]X·(PF6)2 (3: M = Ag, X = BF4; 6: M = Au, X = Cl) respectively. The 1 : 1 reaction of [S-N(Me)CHP]PF6 with AgOTf gave the head-to-tail dimer H,T-[Ag2(μ-N,P-N(Me)CHP)2(μ-OTf)2](PF6)2, 2, whereas the analogous reaction with Au(THT)Cl gave monomeric [Au(κ-P-N(Me)CHP)Cl]PF6, 5. Complex 2 was converted to H,T-[Ag2(μ-C,P-N(Me)CP)2](PF6)2, 4, upon addition of base, while 6 gave [Au(κ-C-N(Me)CP)2]Cl, 8, when treated likewise. Reaction of [S-N(Me)CHP]PF6 with Ni(1,5-COD)2 gave the oxidative addition/insertion product [Ni(κ(3)-N,C,P-N(Me)CP)(η(3)-C8H13)]PF6, 9, which converted to [Ni(κ(3)-N,C,P-N(Me)CP)Cl]PF6, 10, upon exposure of a CHCl3 solution to air. Complex 10 showed conformational isomerism that was also present in [Rh(κ(3)-N,C,P-N(Me)CP)(CO)]PF6, 14, prepared from the precursor complex [Rh(κ-P-N(Me)CHP)(acac)(CO)]PF6, 13, upon heating in C6H5Cl. [Pt(κ(3)-N,C,P-N(Me)CP)(Cl)]PF6, 12, derived from trans-[Pt(κ-P-N(Me)CHP)2(Cl)2](PF6)2, 11, was isolated as a single conformer.

Structurally optimised BODIPY derivatives for imaging of mitochondrial dysfunction in cancer and heart cells

BODIPY based optical imaging agents with mitochondrial membrane potential dependent uptake are described.